Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06400498 · ClinicalTrials.gov registry record · NA

Surprise Question in End of Life (SeQuEL) Care and the Effect of Prompting Palliative Care Consultation: End-Stage Liver Disease

A NA study of End Stage Liver DIsease, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
97
Enrollment target
1
Study location

NCT06400498 is a NA study of End Stage Liver DIsease that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 97 participants, below the 485-participant average among 16 other End Stage Liver DIsease trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06400498, a NA study of End Stage Liver DIsease, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
97 participants
Enrollment target
1
Study location

Study Summary

This is a single center randomized platform trial determining whether prompting consideration of palliative care consultation through the electronic health record impacts the number of palliative consultations placed and hospital-free days among hospitalized adults with End-Stage Liver Disease.

Conditions Studied

End Stage Liver DIsease

Interventions

  • BEHAVIORAL Prompted Palliative Care Consult

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2024-08-05
Est. Completion 2025-08-05
Phase NA

Sponsor

Vanderbilt University Medical Center

677 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06400498

The ClinicalTrials.gov registry entry for NCT06400498 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 485-participant average among 16 other End Stage Liver DIsease trials with a reported enrollment target (80% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Liver DIsease appearing as the primary indexed condition, and to 1 intervention - of which Prompted Palliative Care Consult is the first listed.

NCT06400498 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT06400498 about?

NCT06400498 is a clinical study titled "Surprise Question in End of Life (SeQuEL) Care and the Effect of Prompting Palliative Care Consultation: End-Stage Liver Disease". This is a single center randomized platform trial determining whether prompting consideration of palliative care consultation through the electronic health record impacts the number of palliative consultations placed and hospital-free days among hospitalized adults with End-Stage Liver Disease.

What is the current status of trial NCT06400498?

This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2024-08-05. Estimated completion is 2025-08-05.

What conditions does trial NCT06400498 study?

This clinical trial studies the following conditions: End Stage Liver DIsease.

What interventions are being tested in trial NCT06400498?

The interventions under investigation include: Prompted Palliative Care Consult (BEHAVIORAL).

Who is sponsoring clinical trial NCT06400498?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06400498 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Liver DIsease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Liver DIsease

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.